We are live on ! Find out more
AIM

Alambic Investment Management Portfolio holdings

AUM $9.12M
1-Year Est. Return 34.55%
This Fund
S&P 500
This Quarter Est. Return
-22.45%
1 Year Est. Return
+34.55%
3 Year Est. Return
+47.56%
5 Year Est. Return
+107.87%
10 Year Est. Return
AUM
$238M
AUM Growth
+$112M
Cap. Flow
+$162M
Cap. Flow %
68.24%
Top 10 Hldgs %
11.92%
Holding
433
New
159
Increased
104
Reduced
40
Closed
129

Sector Composition

Rank Sector Weight
1 Industrials 22.48%
2 Technology 19.1%
3 Consumer Discretionary 16.4%
4 Healthcare 11.8%
5 Materials 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACHN
251
DELISTED
Achillion Pharmaceuticals
ACHN
$213K 0.09%
+133,698
New +$378K
VIVO
252
DELISTED
Meridian Bioscience Inc
VIVO
$211K 0.09%
12,132
-23,700
-66% -$404K
ECOM
253
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$209K 0.09%
+18,441
New +$207K
RDI icon
254
Reading International Class A
RDI
$33.2M
$192K 0.08%
+13,218
New +$199K
LMB icon
255
Limbach Holdings
LMB
$553M
$190K 0.08%
+51,541
New +$378K
RYAM icon
256
Rayonier Advanced Materials
RYAM
$590M
$190K 0.08%
17,800
-2,600
-13% -$35.4K
AVID
257
DELISTED
Avid Technology Inc
AVID
$181K 0.08%
38,174
-104,178
-73% -$601K
SM icon
258
SM Energy
SM
$7.73B
$175K 0.07%
11,300
+4,300
+61% +$99.4K
WTI icon
259
W&T Offshore
WTI
$575M
$170K 0.07%
+41,243
New +$263K
LNTH icon
260
Lantheus
LNTH
$6.57B
$169K 0.07%
10,774
-9,889
-48% -$151K
F icon
261
Ford
F
$55.7B
$167K 0.07%
+21,800
New +$194K
NXGN
262
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$156K 0.07%
10,279
-9,792
-49% -$168K
ZAGG
263
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$156K 0.07%
+15,910
New +$179K
JYNT icon
264
The Joint Corp
JYNT
$121M
$152K 0.06%
+18,254
New +$144K
ARA
265
DELISTED
American Renal Associates Holdings, Inc
ARA
$149K 0.06%
12,917
-20,256
-61% -$346K
EIGI
266
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$145K 0.06%
+21,800
New +$181K
ULBI icon
267
Ultralife
ULBI
$119M
$141K 0.06%
+20,899
New +$152K
TTPH
268
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$130K 0.05%
5,744
+1,359
+31% +$53.1K
SURF
269
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$127K 0.05%
+30,066
New +$232K
SDPI
270
DELISTED
Superior Drilling Products Inc.
SDPI
$125K 0.05%
+106,898
New +$283K
CYH icon
271
Community Health Systems
CYH
$400M
$124K 0.05%
+44,100
New +$151K
AGTC
272
DELISTED
Applied Genetic Technologies Corporation
AGTC
$119K 0.05%
47,600
+23,309
+96% +$137K
ENZ
273
DELISTED
Enzo Biochem, Inc.
ENZ
$114K 0.05%
41,097
-53,162
-56% -$174K
DHX icon
274
DHI Group
DHX
$166M
$108K 0.05%
71,138
-52,034
-42% -$89.9K
INTT icon
275
inTEST
INTT
$168M
$107K 0.05%
+17,532
New +$120K

Similar funds

Alambic Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Alambic Investment Management held 433 positions worth $238M, up 88% from $126M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Alambic Investment Management deployed $162M of net new capital in Q4 2018, opening 159 new positions and adding to 104 existing holdings. Its largest new stake was Builders FirstSource: 252,247 shares worth $2.75M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Accuray, an estimated $648K trimmed.

  • Alambic Investment Management's largest Q4 2018 buy was Builders FirstSource: 252,247 shares worth $2.75M.
  • Alambic Investment Management added most to Yellow Corporation Common Stock in Q4 2018, an estimated $4.3M increase.
  • Alambic Investment Management's biggest Q4 2018 reduction was Accuray, cutting an estimated $648K.
  • Alambic Investment Management fully exited Xcerra Corporation in Q4 2018, selling an estimated $1.73M.
  • Alambic Investment Management's ten largest holdings make up 12% of its $238M portfolio in Q4 2018.
  • Alambic Investment Management opened 159 new positions and closed 129 in Q4 2018.
  • Alambic Investment Management's portfolio value rose 88% quarter-over-quarter to $238M.

Based on Alambic Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.